TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Communiqué de presse : Sanofi investit 50 millions d’euros au Trait pour accélérer la production de médicaments innovants

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Charles Wolf, Sanofi France Director
Communiqué de presse : Sanofi investit 50 millions d’euros au Trait pour accélérer la production de médicaments innovants

Sanofi is investing 50 million euros in a new biotechnology production unit at its Le Trait industrial site in Normandy, France. The facility will increase production capacity for biological medications, support 3 major monoclonal antibodies, and serve 44 countries while emphasizing environmental sustainability.

Insights
SNY   positive

The company is making a significant strategic investment in French manufacturing, expanding production capabilities, demonstrating commitment to innovation, and pursuing environmental goals